Related Experiment Video
Updated: May 9, 2026
Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
A new approach for prediction of tumor sensitivity to targeted drugs based on functional data
Noah Berlow1, Lara E Davis, Emma L Cantor
1Department of Electrical and Computer Engineering, Texas Tech University, Lubbock, TX, USA.
Background:
The success of targeted anti-cancer drugs are frequently hindered by the lack of knowledge of the individual pathway of the patient and the extreme data requirements on the estimation of the personalized genetic network of the patient's tumor. The prediction of tumor sensitivity to targeted drugs remains a major challenge in the design of optimal therapeutic strategies. The current sensitivity prediction approaches are primarily based on genetic characterizations of the tumor sample. We propose a novel sensitivity prediction approach based on functional perturbation data that incorporates the drug protein interaction information and sensitivities to a training set of drugs with known targets.
Results:
We illustrate the high prediction accuracy of our framework on synthetic data generated from the Kyoto Encyclopedia of Genes and Genomes (KEGG) and an experimental dataset of four canine osteosarcoma tumor cultures following application of 60 targeted small-molecule drugs. We achieve a low leave one out cross validation error of <10% for the canine osteosarcoma tumor cultures using a drug screen consisting of 60 targeted drugs.
Conclusions:
The proposed framework provides a unique input-output based methodology to model a cancer pathway and predict the effectiveness of targeted anti-cancer drugs. This framework can be developed as a viable approach for personalized cancer therapy.
Insights
This study introduces a new method to predict anti-cancer drug effectiveness using functional perturbation data, improving personalized cancer therapy. The approach achieved high accuracy in predicting tumor sensitivity to targeted drugs.
Area of Science:
- Oncology
- Computational Biology
- Pharmacogenomics
Background:
- Targeted anti-cancer drug efficacy is limited by incomplete understanding of individual patient pathways and tumor genetic networks.
- Current tumor sensitivity prediction relies heavily on genetic tumor profiling, posing challenges for personalized therapeutic strategies.
- A novel approach is proposed to predict drug sensitivity using functional perturbation data, drug-protein interactions, and known drug sensitivities.
Purpose of the Study:
- To develop a novel framework for predicting tumor sensitivity to targeted anti-cancer drugs.
- To overcome limitations of current genetic characterization-based prediction methods.
- To incorporate functional perturbation data and drug-protein interactions for improved prediction accuracy.
Main Methods:
- Developed a novel sensitivity prediction framework utilizing functional perturbation data.
- Integrated drug-protein interaction information into the prediction model.
- Trained the model using sensitivities to a set of drugs with known targets.
Main Results:
- Demonstrated high prediction accuracy on synthetic data from the Kyoto Encyclopedia of Genes and Genomes (KEGG).
- Validated the framework on an experimental dataset of canine osteosarcoma tumor cultures treated with 60 targeted drugs.
- Achieved a low leave-one-out cross-validation error of less than 10% for canine osteosarcoma tumor cultures.
Conclusions:
- The proposed framework offers a novel input-output methodology for modeling cancer pathways and predicting targeted drug effectiveness.
- This framework represents a viable approach for advancing personalized cancer therapy.
- The method enhances the prediction of tumor sensitivity to targeted therapies.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
01:06Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...